1. Home
  2. MTB vs RMD Comparison

MTB vs RMD Comparison

Compare MTB & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M&T Bank Corporation

MTB

M&T Bank Corporation

HOLD

Current Price

$207.48

Market Cap

30.4B

Sector

Finance

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$244.78

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTB
RMD
Founded
1856
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.4B
36.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
MTB
RMD
Price
$207.48
$244.78
Analyst Decision
Buy
Buy
Analyst Count
18
13
Target Price
$216.08
$289.09
AVG Volume (30 Days)
990.2K
970.0K
Earning Date
01-16-2026
01-29-2026
Dividend Yield
2.91%
0.98%
EPS Growth
19.77
29.59
EPS
16.19
9.77
Revenue
$9,080,000,000.00
$5,257,400,000.00
Revenue This Year
$12.85
$9.85
Revenue Next Year
$3.67
$7.36
P/E Ratio
$12.75
$25.03
Revenue Growth
6.84
9.36
52 Week Low
$150.75
$199.92
52 Week High
$208.26
$293.81

Technical Indicators

Market Signals
Indicator
MTB
RMD
Relative Strength Index (RSI) 69.90 41.85
Support Level $202.73 $241.66
Resistance Level $208.26 $247.45
Average True Range (ATR) 3.42 5.02
MACD 0.32 -0.37
Stochastic Oscillator 92.88 14.57

Price Performance

Historical Comparison
MTB
RMD

About MTB M&T Bank Corporation

M&T Bank is a US regional bank with roughly $210 billion in assets as of June 30, 2025. Headquartered in Buffalo, New York, the bank's footprint is mostly concentrated in New England and the US Mid-Atlantic. M&T Bank boasts a community banking approach, and boasts over 900 branches in 13 states and Washington, D.C. Apart from retail and commercial banking, M&T Bank also has wealth management operations through Wilmington Trust and a partnership with LPL Financial, and a corporate trust businesses.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: